Advanced search
1 file | 995.00 KB Add to list

The effect of VEGF-targeted therapy on biomarker expression in sequential tissue from patients with metastatic clear cell renal cancer

(2013) CLINICAL CANCER RESEARCH. 19(24). p.6924-6934
Author
Organization
Project
Bioinformatics: from nucleotids to networks (N2N)
Keywords
PHASE-II, SUNITINIB TREATMENT, ANGIOGENESIS, TUMORS, RESISTANCE, MET, SUPPRESSION, PROGRESSION, CARCINOMA PATIENTS, ANTIANGIOGENIC THERAPY

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 995.00 KB

Citation

Please use this url to cite or link to this publication:

MLA
Sharpe, Kevin, Grant D Stewart, Alan Mackay, et al. “The Effect of VEGF-targeted Therapy on Biomarker Expression in Sequential Tissue from Patients with Metastatic Clear Cell Renal Cancer.” CLINICAL CANCER RESEARCH 19.24 (2013): 6924–6934. Print.
APA
Sharpe, K., Stewart, G. D., Mackay, A., Van Neste, C., Rofe, C., Berney, D., Kayani, I., et al. (2013). The effect of VEGF-targeted therapy on biomarker expression in sequential tissue from patients with metastatic clear cell renal cancer. CLINICAL CANCER RESEARCH, 19(24), 6924–6934.
Chicago author-date
Sharpe, Kevin, Grant D Stewart, Alan Mackay, Christophe Van Neste, Charlotte Rofe, Dan Berney, Irfan Kayani, et al. 2013. “The Effect of VEGF-targeted Therapy on Biomarker Expression in Sequential Tissue from Patients with Metastatic Clear Cell Renal Cancer.” Clinical Cancer Research 19 (24): 6924–6934.
Chicago author-date (all authors)
Sharpe, Kevin, Grant D Stewart, Alan Mackay, Christophe Van Neste, Charlotte Rofe, Dan Berney, Irfan Kayani, Axel Bex, Elaine Wan, Fiach C O’Mahony, Marie O’Donnell, Simon Chowdhury, Rukma Doshi, Colan Ho-Yen, Marco Gerlinger, Dawn Baker, Neil Smith, Barry Davies, Anju Sahdev, Ekaterini Boleti, Tim De Meyer, Wim Van Criekinge, Luis Beltran, Yong-Jie Lu, David J Harrison, Andrew R Reynolds, and Tom Powles. 2013. “The Effect of VEGF-targeted Therapy on Biomarker Expression in Sequential Tissue from Patients with Metastatic Clear Cell Renal Cancer.” Clinical Cancer Research 19 (24): 6924–6934.
Vancouver
1.
Sharpe K, Stewart GD, Mackay A, Van Neste C, Rofe C, Berney D, et al. The effect of VEGF-targeted therapy on biomarker expression in sequential tissue from patients with metastatic clear cell renal cancer. CLINICAL CANCER RESEARCH. 2013;19(24):6924–34.
IEEE
[1]
K. Sharpe et al., “The effect of VEGF-targeted therapy on biomarker expression in sequential tissue from patients with metastatic clear cell renal cancer,” CLINICAL CANCER RESEARCH, vol. 19, no. 24, pp. 6924–6934, 2013.
@article{5333151,
  author       = {Sharpe, Kevin and Stewart, Grant D and Mackay, Alan and Van Neste, Christophe and Rofe, Charlotte and Berney, Dan and Kayani, Irfan and Bex, Axel and Wan, Elaine and O'Mahony, Fiach C and O'Donnell, Marie and Chowdhury, Simon and Doshi, Rukma and Ho-Yen, Colan and Gerlinger, Marco and Baker, Dawn and Smith, Neil and Davies, Barry and Sahdev, Anju and Boleti, Ekaterini and De Meyer, Tim and Van Criekinge, Wim and Beltran, Luis and Lu, Yong-Jie and Harrison, David J and Reynolds, Andrew R and Powles, Tom},
  issn         = {1078-0432},
  journal      = {CLINICAL CANCER RESEARCH},
  keywords     = {PHASE-II,SUNITINIB TREATMENT,ANGIOGENESIS,TUMORS,RESISTANCE,MET,SUPPRESSION,PROGRESSION,CARCINOMA PATIENTS,ANTIANGIOGENIC THERAPY},
  language     = {eng},
  number       = {24},
  pages        = {6924--6934},
  title        = {The effect of VEGF-targeted therapy on biomarker expression in sequential tissue from patients with metastatic clear cell renal cancer},
  url          = {http://dx.doi.org/10.1158/1078-0432.CCR-13-1631},
  volume       = {19},
  year         = {2013},
}

Altmetric
View in Altmetric
Web of Science
Times cited: